基于百分位事件时间测试的II期临床试验设计的数据驱动监测
1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin.
Journal of biopharmaceutical statistics
|December 22, 2023
概括
现在,II期临床试验可以使用百分位事件时间测试 (PETT) 来评估药物的疗效. 这种方法克服了当没有观察到中位生存时间时的中位事件时间测试 (METT) 的局限性.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 药理学 药理学是指药理学的学科.
背景情况:
- 第二阶段临床试验旨在评估新药的治疗疗效.
- 经常使用时间到事件的终点,例如中位生存时间.
- 中位事件时间测试 (METT) 在没有观察到中位生存时存在局限性.
研究的目的:
- 为II期临床试验提出一个概括百分位事件时间测试 (PETT).
- 为使用PETT的临床试验设计开发数据驱动的监测方法.
- 解决METT在快速累积或高治愈率的场景中的局限性.
主要方法:
- 将中位事件时间测试 (METT) 概括为生存时间 (PETT) 的任何百分点.
- 为II期临床试验设计制定数据驱动的监测策略.
- 通过模拟和用临床试验示例示例进行绩效评估.
主要成果:
- 拟议的百分位事件时间测试 (PETT) 为METT提供了一个灵活的替代方案.
- 基于PETT的数据驱动监测可以增强临床试验设计.
- 模拟证明了该方法在各种场景中的有效性.
结论:
- 在第二阶段试验中,PETT提供了一种可靠的方法来分析时间到事件数据.
- 开发的方法解决了临床试验监测中的实际挑战.
- PETT和相关的监测策略改善了治疗疗效的评估.
更多相关视频
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.6K
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.8K
相关概念视频
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Kaplan-Meier Approach
149
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
149
Survival Curves
164
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
164
Hazard Ratio
129
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
129
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
